TY - JOUR
T1 - Essential role of C-Rel in nitric-oxide synthase-2 transcriptional activation
T2 - Time-dependent control by salicylate
AU - Cieslik, Katarzyna A.
AU - Deng, Wu Guo
AU - Wu, Kenneth K.
PY - 2006
Y1 - 2006
N2 - To determine the role of C-Rel in nitric-oxide synthase-2 (NOS-2) transcriptional activation, we evaluated the effect of lipopolysaccharide and interferon-γ (LPS/IFNγ) on C-Rel DNA binding in RAW 264.7. LPS/IFNγ-stimulated C-Rel binding peaked at 4 to 8 h and declined at 24 h. Transfection of cells with a C-Rel small interfering RNA abrogated C-Rel binding at all time points. LPS/IFNγ produced superoxide at 4 h, which subsided at 8 h. C-Rel binding and NOS-2 expression were abrogated by superoxide dismutase or apocynin at 4 h, suggesting a key role that superoxide plays in mediating C-Rel binding and NOS-2 transactivation only at 4 h. We have reported previously that salicylate at 10-5 M inhibited LPS/IFNγ-induced CCAAT/enhancer binding protein β (C/EBPβ) binding at 4 h but not at 8 or 24 h. A single dose of salicylate did not inhibit C-Rel binding at any time point. The addition of a second dose of salicylate 4 h before an indicated endpoint suppressed C-Rel but not C/EBPβ or interferon-γ-regulated factor-1 binding at 8 and 24 h. A single dose of salicylate added with LPS/IFNγ inhibited NOS-2 expression only at 4 h. However, salicylate supplement inhibited NOS-2 promoter activities and mRNA and protein levels throughout 24 h. Signal profiling with a panel of inhibitors revealed time-dependent switch of signaling pathways. These results demonstrate temporal regulation of transactivator binding by LPS/IFNγ via evolving signaling pathways. We propose that salicylate inhibits C/EBPβ binding at 4 h and C-Rel binding at 8 and 24 h by targeting related kinases.
AB - To determine the role of C-Rel in nitric-oxide synthase-2 (NOS-2) transcriptional activation, we evaluated the effect of lipopolysaccharide and interferon-γ (LPS/IFNγ) on C-Rel DNA binding in RAW 264.7. LPS/IFNγ-stimulated C-Rel binding peaked at 4 to 8 h and declined at 24 h. Transfection of cells with a C-Rel small interfering RNA abrogated C-Rel binding at all time points. LPS/IFNγ produced superoxide at 4 h, which subsided at 8 h. C-Rel binding and NOS-2 expression were abrogated by superoxide dismutase or apocynin at 4 h, suggesting a key role that superoxide plays in mediating C-Rel binding and NOS-2 transactivation only at 4 h. We have reported previously that salicylate at 10-5 M inhibited LPS/IFNγ-induced CCAAT/enhancer binding protein β (C/EBPβ) binding at 4 h but not at 8 or 24 h. A single dose of salicylate did not inhibit C-Rel binding at any time point. The addition of a second dose of salicylate 4 h before an indicated endpoint suppressed C-Rel but not C/EBPβ or interferon-γ-regulated factor-1 binding at 8 and 24 h. A single dose of salicylate added with LPS/IFNγ inhibited NOS-2 expression only at 4 h. However, salicylate supplement inhibited NOS-2 promoter activities and mRNA and protein levels throughout 24 h. Signal profiling with a panel of inhibitors revealed time-dependent switch of signaling pathways. These results demonstrate temporal regulation of transactivator binding by LPS/IFNγ via evolving signaling pathways. We propose that salicylate inhibits C/EBPβ binding at 4 h and C-Rel binding at 8 and 24 h by targeting related kinases.
UR - http://www.scopus.com/inward/record.url?scp=33751099601&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33751099601&partnerID=8YFLogxK
U2 - 10.1124/mol.106.026054
DO - 10.1124/mol.106.026054
M3 - Article
C2 - 16963620
AN - SCOPUS:33751099601
SN - 0026-895X
VL - 70
SP - 2004
EP - 2014
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 6
ER -